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Abstract
Background:  Hepatoma Derived Growth Factor (HDGF) is a nuclear protein with nuclear
targeting required for mitogenic activity. Recently we demonstrated that HDGF is a transcriptional
repressor, but whether HDGF binds DNA, the specificity of DNA binding and what protein domain
is required are still unknown. In this study, we aimed to identify if HDGF is a DNA binding protein,
map the functional DNA binding domain and DNA binding element for HDGF.
Results: Using chromatin immunoprecipitation (ChIP) of human DNA, we isolated 10 DNA
sequences sharing a conserved ~200 bp element. Homology analysis identified the binding
sequences as a motif within the promoter of the SMYD1 gene, a HDGF target gene.
Electrophoretic Mobility Shift Assays (EMSA) confirmed the binding of HDGF to this conserved
sequence. As a result, an 80 bp conserved sequence located in the SMYD1 promoter bound GST-
HDGF tightly. The binding core sequence for HDGF was narrowed down to 37 bp using a deletion
mapping strategy from both the 5' and 3' ends. Moreover, ChIP and DNase I footprinting analysis
revealed that HDGF binds this 80 bp DNA fragment specifically. Functionally overexpression of
HDGF represses a reporter gene which is controlled by an SV-40 promoter containing the 80 bp
DNA element. Using serial truncations of GST-HDGF, we mapped the DNA binding domain of
HDGF to the N-terminal PWWP domain.
Conclusion: HDGF is a DNA binding protein, binds DNA specifically, and prefers a minimum of
37 bp long DNA fragment. The N-terminal PWWP domain of HDGF is required for DNA binding.
HDGF exerts its transcription repressive effect through binding to a conserved DNA element in
the promoter of target genes.
Background
Hepatoma derived growth factor (HDGF) is a nuclear pro-
tein with mitogenic activity [1,2]. It is highly expressed in
developing heart and fetal gut [3]; and re-expressed in vas-
cular smooth muscle cells in vivo after vascular injury
[4,5], suggesting that it plays an important role in cardio-
vascular growth and differentiation. Recently by a number
of investigators, HDGF was found to be tumorigenic and
a prognostic factor for a number of cancers [6-11]. We
have discovered that HDGF functions as a transcriptional
repressor, suggesting that HDGF may physiologically reg-
ulate cellular proliferation and differentiation by repress-
ing the genes governing terminal differentiation
(submitted). However using NMR structural analyses, it is
unclear if HDGF is a direct DNA binding protein [12] and
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controversial if the conserved N-terminal PWWP domain
in HDGF is involved in DNA binding [13].
In the present study, using a modified chromatin immu-
noprecipitation (ChIP) assay, we found that HDGF
bound a conserved ~200 base pair sequence common to
an HDGF target gene promoter. EMSA and DNase I foot-
printing analysis revealed that HDGF-DNA interaction is
specific. In EMSA mapping studies, we found HDGF
bound a minimal 37 bp long oligonucleotide and DNA
binding required the HDGF N-terminal PWWP domain.
Furthermore, this DNA sequence is functionally signifi-
cant as HDGF represses a reporter gene which was control-
led by the identified DNA element.
Results
HDGF binds to DNA
HDGF is a nuclear protein [1,2] and we recently have
shown that it functions as a transcriptional repressor (sub-
mitted). However, whether HDGF binds DNA directly
and if so, it's DNA binding specificity are both unknown.
To functionally identify the HDGF DNA binding
sequence we used a modified ChIP assay to identify
homologous sequences, if any, as potential DNA binding
motifs. After 100 clones were sequenced, sequence align-
ment analysis found that there was a group of 10
sequences that shared a ~200 bp highly conserved
sequence (Fig. 1, Additional File 1 and 3). No homolo-
gous sequences were identified in 50 clones which were
immunoprecipitated by a GFP control antibody. A highly
conserved copy was found within the promoter of
SMYD1, a HDGF target gene through database searching
of the human genome (NCBI BLAST). We found this con-
served element located at the promoter -600 to -880 bp
proximal to the start codon. Alignments of the ChIP
sequences with the SMYD1 promoter identified a highly
conserved 80 bp motif (Fig. 1). By ChIP-PCR, we success-
fully amplified this specific region (-702 to -565) from
immunoprecipitated chromatin DNA using a HDGF spe-
cific antibody (Fig. 2A). As a control, no amplification was
observed for a proximal site (-375 to -215). We then veri-
fied HDGF DNA binding using an in vitro competition
EMSA assay. As shown in Figure 2B, the labeled 80 bp
probe bound tightly to GST-HDGF. The binding was spe-
cific as 100 fold of the non-labeled 80 bp probe totally
abolished the binding; however 100 fold of a nonspecific
oligonucleotide competitor had no effect on the binding.
Salmon sperm DNA is known as a strong competitor for
DNA binding. However, as shown in Figure 2C, the bind-
ing of the 80 bp probe to HDGF could be blocked only
Alignment of ChIP clones identify a HDGF binding motif consensus with the SMYD1 gene promoter Figure 1
Alignment of ChIP clones identify a HDGF binding motif consensus with the SMYD1 gene promoter. ChIP was 
carried out as described in method. Totally 100 clones were sequenced, and 10 of them share a conserved region. The figure 
shows that these 10 clones were aligned with human SMYD1 gene promoter homologue region using ClustalW program. The 
genomic and chromosome location were indicated at the beginning and ending of each sequences. The solid line indicates the 
sequence of the 80 bp probe for EMSA.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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when the concentration of salmon sperm DNA reached 2
ug, which is approximately a 30,000 molar fold excess to
the input labeled oligo (0.25 pmol). In addition, HDGF
binding was not an artifact of using GST tagged HDGF as
an EMSA using another tagged protein, His-HDGF, or
non-tagged in vitro translated HDGF, all demonstrated
equivalent tight binding to the EMSA probe (Fig. 2D).
From these results, we conclude that HDGF binds an 80
bp DNA sequence conserved within the promoter of the
HDGF target gene SMYD1.
HDGF binds a 37 bp long DNA motif specifically
To determine the HDGF core binding sequence, we made
serial deletion oligonucleotides from the 3' end of the 80
bp probe, which we tested by EMSA for HDGF binding. As
shown in Figure 3A, the binding was completely lost with
a probe shorter than 50 bp. To further narrow down the
DNA recognition motif, we first took out another 4 bp at
the 3' end of this 50 bp probe in Figure 3A, then made
another serial deletion set from the 5' end based on the 46
bp probe. As shown in Figure 3B, incremental deletion of
the 5' end of the 46 bp probe, identified a 37 bp motif that
is required for HDGF binding. A 37 bp DNA motif
required for DNA binding is relatively long. In fact we
could not detect any HDGF DNA binding when we used
5 short DNA probes which are all 15 bp long with a 5 bp
overlap, covering the central part of the 80 bp oligo (Data
not shown).
We also performed DNase I footprinting assay to deter-
mine the specificity of HDGF-DNA interaction. As shown
in Figure 4, GST-HDGF can protect part of the 80 bp DNA
fragment from DNase I digestion. The DNA fragment used
in footprinting analysis is the same as the probe used in
EMSA. The protected region starts from 34 bp from the 3'
end (which correlates to the -642 bp in SMYD1 gene pro-
moter) to 5' end. We could not get a clear footprint of 5'
end because it is too close to the 5' of the DNA fragment
we used. However, the result is consistent with the data of
EMSA, that the 5' of the 80 bp DNA fragment is critical for
HDGF-DNA interaction. These data indicated that HDGF
binds DNA specifically, but the binding requires a large
DNA molecule.
Overexpression of HDGF represses a reporter gene when 
controlled by the HDGF binding element
In order to study whether the HDGF binding element in
SMYD1 gene promoter is functional, we cloned the 80 bp
oligo described above upstream of the SV40 promoter, so
that the HDGF binding element (Hcis)-SV40 controls the
downstream luciferase gene. Co-transfection of HDGF
with this reporter (Hcis-SV40-LUC) significantly
repressed the reporter gene activity in a dose dependent
manner (Fig 5A). As a control, overexpression of HDGF
had no effect on the reporter without the HDGF binding
element (Fig 5B). These experiments indicate that HDGF
exerts its repressive effect through binding with the HDGF
binding element directly.
PWWP domain is required for DNA binding
A PWWP domain spanning approximately 90 AA is
present in the N-terminal of HDGF [14]. Although contro-
versial, the PWWP domain is reported to have the capabil-
ity of binding DNA as has been shown for DNA
methyltransferase 3B (DNMT3b) [13,15-17]. In order to
study whether the HDGF PWWP domain is responsible
for DNA binding, we made several truncated HDGF
fusion proteins to test for DNA binding in EMSA experi-
ments. As shown in Figure 6, only the truncated proteins
which contain the whole PWWP domain can bind to DNA
(∆1–110, ∆1–140, ∆1–146), whereas proteins lacking the
complete PWWP domain can not bind to DNA. Impor-
tantly the entire PWWP domain is required as fusions con-
taining a portion of the PWWP domain could not bind
(∆70–237) or bound weakly (∆35–237).
Discussion
HDGF is nuclear target protein with nuclear localization
necessary for its mitogenic function [1,2]. Because of these
attributes, it has been hypothesized that HDGF, especially
considering it contains a PWWP domain, is a DNA regula-
tory protein. In this study, we found that HDGF binds
directly to DNA via a specific element contained in the
promoter of a HDGF target gene, SMYD1. Functionally
this DNA binding element also confers transcriptional
repression activity. SMYD1 gene is essential for cardiomy-
ocyte differentiation and cardiac morphogenesis [18], the
regulation of SMYD1 by HDGF is in accord with the func-
tional importance of HDGF in the development of cardi-
ovascular system [3,4], likely playing a role in preventing
terminal differentiation.
We found that HDGF prefers to bind a large DNA mole-
cule, requiring a minimum 37 bp DNA fragment. It is sur-
prising that HDGF binds such a long DNA fragment. In a
recent structural study on the interaction of the HDGF
PWWP domain with DNA, we identified unique altera-
tions in the structure of the HDGF PWWP domain with
the addition of DNA. However we could not confirm
whether these interactions with DNA were specific [12].
This was due to the technical requirements of both SAAB
and NMR for oligonucleotides shorter than 30 bp. In the
present study, with EMSA and longer oligonucleotides we
found that the length of DNA fragment is critical for
HDGF binding. HDGF tightly binds DNA only when the
DNA is ≥37 bp, suggesting that this HDGF/DNA interac-
tion may require a unique DNA structure.
Transcription factor binding sites are usually short, highly
degenerate, and often require specific tertiary structuresBMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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HDGF binds DNA Figure 2
HDGF binds DNA. (A) HDGF binds DNA in vivo. ChIP was carried out as described in method. A specific HDGF polyclonal 
antibody was used to precipitate Hela chromatin, GFP antibody was used as negative control. Recovered DNA was amplified 
by PCR using specific primers. The PCR primers were derived from the human SMYD1 promoter as described in methods. 
The PCR products were analyzed by ethidium bromide staining of a 2% agarose gel. A primer set targeting a proximal site (-
375 to -215) of the SMYD1 promoter was used as a negative control. The numbers on the right indict the location of ampli-
cons in SMYD1 promoter. (B) HDGF binds DNA in vitro. 0.25 pmol 5' end biotin labeled probes for SMYD1 promoter (nucle-
otides -688 to -609) were incubated with 1 ug GST-HDGF fusion protein in the reaction buffer in the presence of either 100 × 
specific or non specific competitors (B) or various amount of sheared salmon sperm DNA (C) on ice for 30 min. The complex 
were resolved in 5% PAGE and transferred onto a nylon membrane. The biotin end-labeled DNA probe is detected using a 
streptavidin-horseradish peroxidase conjugate and chemiluminescent substrate. (D) Different sources of HDGF bind to DNA. 
1 ug of bacterial expressed GST-HDGF, His-HDGF-GFP and in vitro translated HDGF (without tag) were used for EMSA as 
described above.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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[19]. For example estrogen receptor response element
(ERE) is a palindromic motif. However when we analyzed
the 37 bp core sequence for HDGF binding using
EXTRACTFEAT program [20], we could not identify any
special structure such as palindromes or repeated struc-
tures within this 37 bp core HDGF binding sequence. It is
of interest that the 37 bp HDGF DNA binding element is
a component of an Alu DNA repeat. The Alu DNA family
is the most abundant members of the short interspersed
repeated DNA elements (SINEs) which are found in the
genomes of primates exclusively [21,22]. Alu sequences
are approximately 300 bp in length, have a bipartite struc-
ture with left and right arm monomers which are derived
from the 7SL RNA gene. The overall function of these
repeats is unclear, but of interest to the present study,
these repeats containing the HDGF binding sequence are
found within the promoters of all HDGF target genes
identified so far [see Additional File 2].
HDGF is evolutionary relative new. Besides mammals,
HDGF homologs also exist in other organisms, such as
xenopus and rodents. Although Alu DNA is found exclu-
sively in primates, there is homologous SINE DNA in
rodents such as the B1 and B2 DNA elements of the
mouse. More interestingly, the mouse genome is esti-
mated to contain 10,000 copies of a retroposon family
that is closely related to human Alu repeats [23]. Compar-
ative study of the DNA binding in both human and
mouse will give us more information on the conservation
of this binding element.
The N-terminus of HDGF contains a PWWP domain, a
weakly conserved 90 amino acid motif, originally identi-
fied in the WHSC1 gene [24] and as the HATH (homolo-
gous to the amino terminus of HDGF) region in the
HDGF family of proteins [14], it has been found in more
than 60 eukaryotic proteins [24]. Functionally, most of
the PWWP family proteins are involved in chromatin
remodeling [25]. However the role of the PWWP domain
in this function is unknown. We demonstrate the first
functional significance of the PWWP domain as it is nec-
essary and sufficient for binding to the HDGF DNA bind-
ing element. The PWWP domain was hypothesized to be
a site for protein-protein interactions [24]. However, the
PWWP domain of DNMT3b was shown to interact with
DNA [15-17]. In a more detailed investigation, the PWWP
domain of DNMT3b was found to bind major satellite
DNA nonspecifically [17]. However, the PWWP in its clos-
est homologue gene, DNMT3a (60.3% identity) had no
DNA binding activity [17]. This suggests that small
changes in the PWWP domain may have a significant
impact on its DNA binding ability. As the PWWP domain
in HDGF is only 25.9% homologous with DNMT3a, it is
HDGF requires a minimal 37 bp DNA sequence for binding Figure 3
HDGF requires a minimal 37 bp DNA sequence for binding. Sequential 3'(A) or 5' (B) end serial deleted (3–5 bp) 
probes were synthesized and used in an EMSA to identify a minimum DNA binding sequence. The bottom schematic diagram 
elucidates the locations of deleted probes relative to the 80 bp long probe. A 37 bp probe was identified as the minimal DNA 
binding sequence.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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not surprising that HDGF could have a different DNA
binding behavior.
A recent structural study found that under physiological
conditions, both PWWP modules and full length human
HDGF could form dimers [26]. Using the SPR method,
the authors found that PWWP dimer binds to heparin
with higher affinity than that of a monomeric PWWP
module. Several sequence specific DNA binding protein
such as C/EBP, c-Myc, c-Jun and fos form hetero/homo
dimers. Their leucine-zipper motifs do not face with the
DNA. Rather, they form three-dimensional "scaf-carboxy-
lfolds" that match the contour of DNA [27]. Whether
HDGF dimerizes on DNA and utilizes the similar mecha-
nism of DNA recognition remains to be determined.
Conclusion
We have shown that HDGF is a DNA binding protein; spe-
cifically binds a DNA element in the promoter of SMYD1
gene. This DNA/HDGF interaction is unique in that the
minimum required binding element was 37 bp in length.
Importantly the poorly understood N-terminal PWWP
domain of HDGF was responsible for DNA binding.
Taken together HDGF functions in the nucleus as a direct
DNA binding protein to repress the expression of specific




HDGF expression construct (pK7-GFP-HDGF) was
described before [1]. Human HDGF was PCR amplified
from IMAGE clone 5587366 (ATCC) and subcloned in
frame with GST in pGEX-4T2 vector (Amersham Pharma-
cia Biotech) by introducing appropriate restriction sites.
Truncated GST-HDGF constructs were generated by PCR
cloning method. Hcis-SV40-LUC reporter was generated
by inserting the 80 bp oligo which was used in EMSA into
the upstream of SV40 promoter in pGL3 control plasmid
(Promega). All new constructs were confirmed by
sequencing.
ChIP Assay
The manufacturer's (Upstate) protocol was used for for-
maldehyde cross-linking and chromatin immunoprecipi-
tation. A rabbit anti-HDGF polyclonal antibody [1] or a
rabbit anti-GFP antibody (Santa Cruz) as a control, were
used to precipitate chromatin from 2 × 107 Hela cells.
After reverse crosslinking and purification, DNA was
recovered and divided into two fractions. For the cloning
experiment, recovered DNA was ligated with a PCR linker
[28], the linker sequence is 5'-GCGGTGACCCGGGA-
GATCTGAATTC-3'. The ligation product was subjected to
PCR using linker specific primers (the same oligo used as
linker above). PCR products were cloned into pCRScript
HDGF protect DNA from DNase I digestion Figure 4
HDGF protect DNA from DNase I digestion. DNase I 
footprinting analysis of the 80 bp DNA fragment using GST-
HDGF recombinant protein. The DNA fragment is the same 
as the probe used in EMSA corresponding to nucleotides -
688 to -609 of the SMYD1 gene promoter. Numbers on the 
left side indicate the location in the SMYD1 promoter. Pro-
tected sequence is indicated with single line.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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vector according to manufacturer's instruction (Strata-
gene). 100 clones were picked up and sequenced. For
ChIP-PCR experiment, recovered DNA from each sample
was amplified by PCR using specific primers. PCR was car-
ried out as follows: 1 ul of DNA sample, 0.5 uM each
primer, 1.5 mM MgCl2, 0.2 mM each dNTPs, 1 × Taq
buffer (Bio-Rad), 1.25 units of Taq DNA polymerase (Bio-
Rad) in a total volume of 25 ul. After 40 cycles of amplifi-
cation, the PCR products were analyzed by ethidium bro-
mide staining of a 2% agarose gel. Primers used for PCR
of ChIP samples were designed directly from human
SMYD1 promoter sequence obtained from the public data
base (The UCSC Genome Browser). Primer sequences are:
Forward 5'-TCACCATGTTGGTCAGGCTGGTCT-3' (-702
to -679 of start codon), Reverse 5'-AGGGTGGACTGTT-
TAGCAGC-3' (-584 to -565 of start codon). The second
primer set which located at -375 to -215 was used as con-
trol. The sequences are: 5'-AGTGCAAGCCTGACAGCT-
GAAGG-3' and 5'-GGAAGAGTTTCATTCATCACCCAGC-
3'.
Electrophoretic Mobility Shift (EMSA) Assay
GST-HDGF and truncated protein were expressed in the
BL21 (DE3) strain of Escherichia coli using the pGEX-4T2
vector (Amersham Pharmacia Biotech), His-HDGF-GFP
was expressed in pG7-HDGF [1] was also expressed in
BL21 strain, the purification of GST and His recombinant
proteins were followed the manufacture's instructions.
TNT-HDGF protein was translated in vitro using the TNT
kit (Promega) and a pcDNA3.1 based expression plasmid
encoding full-length HDGF without tag. EMSA was per-
formed according to manufacture's instruction (Pierce,
LightShift Chemiluminescent EMSA Kit). Briefly, 1 ug
purified recombinant HDGF or truncated HDGF protein
was incubated with 0.25 pmol 5' end biotin labeled dou-
ble-stranded oligonucleotide in the reaction buffer (10
mM Tris pH 7.5, 50 mM KCl, 1 mM DTT, 5% glycerol,
0.05% NP-40, 0.1 ug sheared salmon sperm DNA) for 30
min on ice. The reaction mixture was loaded onto a 5%
non-denaturing polyacrylamide gel. The gel was run in 0.1
× TBE buffer at 200 V for 2 hours. DNA-protein complex
were transferred to a nylon membrane in 0.5 × TBE buffer
and UV crosslinked. The biotin end-labeled DNA probe
was detected using a streptavidin-horseradish peroxidase
conjugate and the chemiluminescent substrate. The 80 bp
double stranded oligo probe is located at -688 to -609 of
SMYD1 promoter (+1 is the start codon), the sequence of
biotin labeled sense strand is 5'-Bio-CAGGCTGGTCTTG
AACTCCTGACCTCAGATGATCCATGTGCCTCGGCCTC-
CCAAGGTGGGGATTACAGGCGTGAGCCACC-3'. The
sequence of sense strand of non-specific competitor is 5'-
TGCTGTTGACAGTGAGCGCGGCCAGCTTATAGTCATAT
ATTAGTGAAGCCACAGATGTAATATATGACTATAAGCT-
HDGF represses the transcription of a reporter which is controlled by the HDGF DNA binding element Figure 5
HDGF represses the transcription of a reporter which is controlled by the HDGF DNA binding element. The 80 
bp oligo (Hcis) was cloned upstream of the SV40 promoter which controls a downstream luciferase reporter gene. 0.5 ug Hcis-
SV40-LUC reporter construct (A) or SV40-LUC control reporter (B) were cotransfected with various amount (0.1, 0.3, 0.5 
ug) of GFP-HDGF. 0.1 ug pRL-CMV were included as transfection control. The dual-luciferase reporter assay system was used 
to measure the luciferase activities 24 hours after transfection. Percentage of firefly luciferase activity was calculated when luci-
ferase activity from the reporter gene alone was set at 100%. Firefly luciferase activity was normalized with constitutive renilla 
luciferase activity to correct for transfection efficiency. Bars indicate mean ± SEM from 3 separate transfection assays with 
duplicate plates, *P < 0.05 by one-way ANOVA control versus GFP-HDGF.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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GGCCTTGCCTACTGCCTCGGA. All of the DNA probes
were synthesized by IDT DNA Inc.
DNase I footprinting analysis
We used a non-radioactive detection method for DNase I
footprinting analysis. DNA fragment covers -688 to -609
of SMYD1 promoter (+1 is the start codon) was used in
this experiment, the sequence is the same as the 80 bp
oligo probe used in EMSA. Binding reactions (100 µL)
comprised 1 ug purified recombinant HDGF protein, 0.25
pmol double-stranded oligonucleotide (5' end of sense
strand was labeled by biotin), 10 mM Tris pH 7.5, 50 mM
KCl, 1 mM DTT, 5% glycerol, 0.05% NP-40, 0.1 ug
sheared salmon sperm DNA, the reaction mixture was
incubated on ice for 30 min. One volume of 10 mM
MgCl2 5 mM CaCl2 was added. Each reaction mixture was
then treated with increasing amounts of DNase I, from
0.01 to 0.1 Kunitz units (Worthington) for 120 seconds
and stopped by adding 200 µL stop solution (1% sodium
dodecyl sulphate, 200 mM NaCl, 20 mM EDTA pH 8.0, 40
mg/mL yeast tRNA). Reactions were extracted once with
one volume of phenol-chloroform, and precipitated with
two volumes of ethanol at -80°C for 60 minutes. Reac-
tions were centrifuged for 15 minutes at 13,200 g. DNA
pellets were washed with 80% ethanol and air dried. Pel-
lets were resuspended in 5 µL of loading buffer (95% for-
mamide, 20 mM EDTA, 0.05% Bromophenol Blue,
0.05% Xylene Cyanol FF). Reactions were loaded on a 6%
(19:1 acrylamide:bis-acrylamide) polyacrylamide
sequencing gel containing 7 M urea and 1 × TBE (89 mM
Tris base, 89 mM boric acid, 2.5 mM EDTA). The gel was
run at 50 watts in 1 × TBE buffer. The DNA fragments were
transferred to a charged Nylon membrane and detected
using Chemiluminescent Nucleic Acid Detection Module
(Pierce, 89880).
Cell Culture and Transient Transfection
G7 myoblast cells were purchased from ATCC and main-
tained in Dulbecco's Modified Eagle's medium (DMEM)
with 10% fetal calf serum and 10% horse serum (ATCC).
Transient transfection assays were performed using
FuGENE6 (Roche) according to the manufacturer's
instruction. G7 cells in 6 well plates were transfected with
0.5 ug of Hcis-SV40-LUC reporter construct and 0.1–0.5
ug of pK7-GFP-HDGF or pK7-GFP vector as control, 0.1
ug of pRL-CMV was cotransfected as internal control, the
total DNA concentration was held constant by adding
empty vector. 24 hours after transfection, Luciferase assays
were performed using a Dual-Luciferase Reporter Assay
Systems (Promega). 20 ul of cell lysate was measured in a
Monolight 2010 luminometer (Analytical Luminescence
Laboratories) as described in the manufacturer's manual.
Firefly luciferase activity was normalized for Renilla luci-
ferase activity. All transfection data are represented as the
mean ± SEM of at least 3 independent experiments per-
formed in duplicate.
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PWWP domain is required for HDGF DNA binding Figure 6
PWWP domain is required for HDGF DNA binding. 
EMSA was carried out as described above using truncated 
recombinant HDGF protein. The bottom panel is a sche-
matic illustration of the GST-HDGF truncated polypeptides 
generated to determine the region(s) of HDGF that allow for 
binding with the 80 bp DNA probe. The PWWP domain is 
located at amino acids 1–90. NLS represents the location of 
the HDGF nuclear localization sequence.BMC Molecular Biology 2007, 8:101 http://www.biomedcentral.com/1471-2199/8/101
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Additional file 1
Location of ChIP sequences within human genome. The data shows the 
chromosome location and alignment of ChIP clones 1–10 to human 
genome.




Genomic location of ChIP clones. The data shows the chromosome loca-
tion and alignment of non-specific ChIP clones 11–100 to human 
genome.




The alignment of binding core in 5 candidate gene promoters. The data 
shows the location of binding core in the promoters of 5 candidate genes, 
and their alignment.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2199-8-101-S2.pdf]